retatrutide triple agonist glp-1 gip glucagon phase 3 2025 Retatrutide (40mg) PDB-101: Molecule of the Month:

Zepbound is administered as a subcutaneous injection in the stomach, thigh, or upper arm once a week on the same day every week

A randomized, controlled trial of 3.0 mg of Liraglutide in weight management

But the popularity of weight-loss drugs has ushered in something different altogether

Diabetes, heart failure and beyond: elucidating the cardioprotective mechanisms of sodium glucose cotransporter 2 (SGLT2) inhibitors

What Zepbound doses are available in vials

Aesthetically, the loss of muscle can reveal or worsen skin laxity, leading to concerns about hollowing in the face and changes in body contour, often described by patients as Ozempic face